搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Clostridium acetobutylicum Protein CrcB homolog 2 (crcB2), partial CSB-YP836438DUB1
CSB-EP836438DUB1
CSB-BP836438DUB1
CSB-MP836438DUB1
CSB-EP836438DUB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Putative 30S ribosomal protein S4 B (rpsD2) CSB-YP836439DUB
CSB-EP836439DUB
CSB-BP836439DUB
CSB-MP836439DUB
CSB-EP836439DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Cobalamin synthase (cobS), partial CSB-YP836440DUB1
CSB-EP836440DUB1
CSB-BP836440DUB1
CSB-MP836440DUB1
CSB-EP836440DUB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Probable phosphoketolase (CA_C1343), partial CSB-YP836441DUB
CSB-EP836441DUB
CSB-BP836441DUB
CSB-MP836441DUB
CSB-EP836441DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum 30S ribosomal protein S21 (rpsU) CSB-YP836442DUB
CSB-EP836442DUB
CSB-BP836442DUB
CSB-MP836442DUB
CSB-EP836442DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Probable septum site-determining protein MinC (minC) CSB-YP836443DUB
CSB-EP836443DUB
CSB-BP836443DUB
CSB-MP836443DUB
CSB-EP836443DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Probable M18 family aminopeptidase 1 (apeA) CSB-YP836444DUB
CSB-EP836444DUB
CSB-BP836444DUB
CSB-MP836444DUB
CSB-EP836444DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Phosphoribosyl-AMP cyclohydrolase (hisI) CSB-YP836445DUB
CSB-EP836445DUB
CSB-BP836445DUB
CSB-MP836445DUB
CSB-EP836445DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP836446DUB
CSB-EP836446DUB
CSB-BP836446DUB
CSB-MP836446DUB
CSB-EP836446DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Tyrosine--tRNA ligase 2 (tyrS2) CSB-YP836447DUB
CSB-EP836447DUB
CSB-BP836447DUB
CSB-MP836447DUB
CSB-EP836447DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Altronate oxidoreductase (uxaB) CSB-YP836448DUB
CSB-EP836448DUB
CSB-BP836448DUB
CSB-MP836448DUB
CSB-EP836448DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP836449DUB
CSB-EP836449DUB
CSB-BP836449DUB
CSB-MP836449DUB
CSB-EP836449DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum UPF0042 nucleotide-binding protein CA_C0511 (CA_C0511) CSB-YP836450DUB
CSB-EP836450DUB
CSB-BP836450DUB
CSB-MP836450DUB
CSB-EP836450DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Phosphoglucosamine mutase (glmM) CSB-YP836451DUB
CSB-EP836451DUB
CSB-BP836451DUB
CSB-MP836451DUB
CSB-EP836451DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP836452DUB1
CSB-EP836452DUB1
CSB-BP836452DUB1
CSB-MP836452DUB1
CSB-EP836452DUB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum L-Ala-D/L-Glu epimerase (CA_C0192) CSB-YP836453DUB
CSB-EP836453DUB
CSB-BP836453DUB
CSB-MP836453DUB
CSB-EP836453DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Adenylyl-sulfate kinase (cysC) CSB-YP836454DUB
CSB-EP836454DUB
CSB-BP836454DUB
CSB-MP836454DUB
CSB-EP836454DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Bacteriohemerythrin (CA_C0069) CSB-YP836455DUB
CSB-EP836455DUB
CSB-BP836455DUB
CSB-MP836455DUB
CSB-EP836455DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Chromosomal replication initiator protein DnaA (dnaA) CSB-YP836456DUB
CSB-EP836456DUB
CSB-BP836456DUB
CSB-MP836456DUB
CSB-EP836456DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Histidine--tRNA ligase (hisS) CSB-YP836457FMW
CSB-EP836457FMW
CSB-BP836457FMW
CSB-MP836457FMW
CSB-EP836457FMW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>